Back to dashboard
Episode 175
DIP Episode 175 - USMLE Step 2CK Rapid Review Series 23 (Psych)
MixedMedium4 - HighHas Q&A
Step 2Step 3MedicineUSMLEStep 2Step 3
Topic
Eating disorders; Electrolyte imbalances (vomiting); Drug toxicity (INH, MAOIs); Neurotransmitter deficits (Dopamine, Acetylcholine, GABA)...
Key Takeaway
The differential diagnosis of neuropsychiatric syndromes requires correlating clinical presentation with specific neurotransmitter deficiencies and understanding the unique pharmacological mechanisms of drug-induced seizures or metabolic derangements.
Runtime: 29.4 min
Published: 2019-10-23
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: RAPID REVIEW SERIES
Episode Notes
Source / episode info
- Episode: 175
- Title: Divine Intervention Episode 175 – USMLE Step 2 CK Rapid Review Series 23 (Psych).
- Published: 2019-10-23
- Source: Episode page
One-liner
This episode reviews high-yield psychiatric topics including differentiating anorexia nervosa from bulimia and binge eating disorder; managing electrolyte imbalances secondary to vomiting; recognizing neurotransmitter deficits in various syndromes (e.g., PD vs. Lewy Body Dementia); and mastering the acute management of mania, stress disorders, and drug toxicities like isoniazid seizures.
High-yield summary
- Anorexia Nervosa: Requires a BMI below normal weight AND distorted body image; must be distinguished from Bulimia (binge + compensatory behavior) and Binge Eating Disorder (binge only).
- Vomiting/Electrolytes: Chronic vomiting leads to hypochloremia, metabolic alkalosis, and volume depletion -> activation of RAAS -> hypokalemia.
- Cocaine Overdose: Presents as a hypertensive crisis due to sympathomimetic effects (_1 agonism). Treatment requires an -blocker (e.g., Phentolamine) or benzodiazepine; avoid -blockers due to unopposed -stimulation.
- Neurotransmitter Syndromes: Parkinson's disease involves low dopamine; Lewy Body Dementia is characterized by low dopamine and low acetylcholine, with dementia preceding motor symptoms.
- Myasthenia Gravis (MG): Autoantibodies against the nicotinic A Ch receptor; diagnosis confirmed by improvement after an acetylcholinesterase inhibitor (e.g., Neostigmine/Tensilon).
- Isoniazid Toxicity: Requires mandatory Vitamin B6 supplementation because INH depletes pyridoxal phosphate, leading to decreased glutamate decarboxylase activity -> low GABA and high glutamate levels, predisposing to seizures.
Learning objectives
- Differentiate the diagnostic criteria for Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder based on weight status and compensatory behaviors.
- Predict the expected electrolyte abnormalities (hypochloremia, hypokalemia, metabolic alkalosis) following chronic vomiting.
- Outline the management of hypertensive crises related to sympathomimetic drug use or dietary triggers (MAO Is).
- Correlate specific neurotransmitter deficiencies (e.g., low A Ch in MG/AD; low DA in PD/DLB) with clinical syndromes and appropriate diagnostic tests.
- Determine the acute first-line management for severe mania versus chronic bipolar disorder exacerbations.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Anorexia Nervosa | BMI < normal weight; distorted body image | Purging/excessive exercise | Must be underweight to diagnose AN. |
| Cocaine Overdose | Hypertensive crisis, rhabdomyolysis | _1 agonism (Sympathomimetic) | Use an -blocker or Benzo; never use a -blocker. |
| Myasthenia Gravis | Fluctuating muscle weakness | Nicotinic A Ch receptor antibodies | Tensilon test (A ChE inhibitor) improves symptoms. |
| Parkinson's Disease | Bradykinesia, rigidity | Low Dopamine | Dementia usually occurs much later in the disease course. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Eating Disorders | AN (underweight) vs Bulimia (normal/overweight) vs Binge ED (any weight) | Defining criteria based on body mass index and compensatory behaviors. | High-yield distinction question; focus on the absence of purging for BED. |
| Vomiting Electrolytes | Hypochloremia, Metabolic Alkalosis, Hypokalemia | Loss of gastric acid ({H Cl}) leads to alkalosis; volume depletion activates RAAS -> K+ wasting. | Classic triad associated with chronic vomiting/vomitor's syndrome. |
| Acute Mania Management | Anti-psychotic (e.g., Haloperidol) is first line. | Acute, severe manic episode. | Mood stabilizers are too slow to take effect in acute mania; anti-psychotics provide rapid control. |
| Neurotransmitter Deficits | Low A Ch/Low DA vs High Dopamine | MG: low A Ch (nicotinic receptor); PD: low DA; Huntington's: high DA, low GABA/A Ch. | Requires linking the specific deficit to the syndrome and its treatment. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient presents with a BMI of 17, reports excessive exercise and purging, and has hypokalemia/metabolic alkalosis. | Anorexia Nervosa (Purging Type) | Low weight is mandatory for anorexia; vomiting causes the classic electrolyte triad (hypo Cl, hypo K, metabolic alkalosis). |
| A patient presents with episodes of binge eating but denies compensatory behaviors like purging or excessive exercise. | Binge Eating Disorder | The defining feature separating it from bulimia nervosa is the absence of compensatory behavior. |
| A patient has a hypertensive crisis following consumption of aged cheese and wine while taking an MAO inhibitor. | Tyramine reaction (MAOI-induced) | Aged foods contain high levels of tyramine, which causes massive norepinephrine release when MAO Is are present, leading to severe hypertension. |
| A 40-year-old patient with a history of MG is tested and shows improvement in muscle strength after administration of neostigmine. | Myasthenia Gravis (MG) | MG involves autoantibodies against the nicotinic A Ch receptor; improving symptoms with an A ChE inhibitor confirms the diagnosis. |
| A patient on isoniazid for tuberculosis develops seizures, despite adequate B6 supplementation being initiated. | Drug-induced seizure/Metabolic derangement | INH depletes pyridoxal phosphate (B6), impairing GABA synthesis and leading to a low GABA/high glutamate state, predisposing to seizures. |
| A 70-year-old man with Parkinsonian symptoms who develops visual hallucinations and dementia years before motor decline. | Dementia with Lewy Bodies (DLB) | The sequence of cognitive impairment preceding parkinsonism is characteristic of DLB, distinguishing it from typical PD. |
Differential diagnosis / distinguishing features
Myasthenia Gravis vs Congenital Myasthenic Syndrome (CMS)
| Key Features | Distinguishing Findings | Next Step |
| Myasthenia Gravis | Autoantibodies against nicotinic A Ch receptor; fluctuating weakness | Symptoms improve with acetylcholinesterase inhibitors (e.g., Neostigmine/Tensilon). |
| Congenital Myasthenic Syndrome | Genetic defect in A Ch synthesis or receptors; fixed, non-fluctuating weakness | Does NOT improve with acetylcholinesterase inhibitors because the enzyme is not rate-limiting. |
Parkinson's Disease vs Dementia with Lewy Bodies (DLB)
| Key Features | Distinguishing Findings | Next Step |
| Parkinson's Disease | Bradykinesia, rigidity; motor symptoms often precede cognitive decline. | Dopaminergic replacement therapy (L-DOPA). |
| Lewy Body Dementia | Visual hallucinations and fluctuating cognition; dementia precedes parkinsonism. | Cholinergic agents (e.g., Donepezil) and antipsychotics with caution. |
Management pearls
- For acute mania, the initial treatment of choice is an anti-psychotic agent due to its rapid onset of action compared to mood stabilizers like lithium or lamotrigine.
- When managing a patient on MAO Is who consumes tyramine-rich foods (e.g., aged cheese), administer immediate supportive care and potentially an \alpha-blocker; benzodiazepines are preferred over other agents for acute crisis management in this setting.
- In the workup of seizures following INH use, always check Vitamin B6 status and provide supplementation to prevent GABA deficiency.
- For suspected MG, a positive Tensilon test (improvement after A ChE inhibitor) is highly diagnostic, but remember that CMS will not improve with these agents.
Don't miss
🚨
Anorexia Nervosa: The patient must be underweight for the diagnosis.
🚨
Cocaine Overdose: Never give a \beta-blocker due to the risk of unopposed \alpha-stimulation, which can precipitate severe hypertension and rhabdomyolysis.
🚨
Acute Mania: Anti-psychotics are first-line; mood stabilizers take too long to become effective in an acute crisis.
🚨
Neurotransmitter Deficits: Remember the sequence: DLB (Dementia -> PD) vs. typical PD (PD -> Dementia).
Integration & clinical reasoning
- The management of hypertensive crises (Cocaine, MAO Is/Tyramine) shares common principles: rapid control of sympathetic outflow using agents that block \alpha-receptors or enhance GAB Aergic activity (Benzodiazepines).
- Electrolyte imbalances from vomiting are a classic example of metabolic derangement driven by GI losses (\text{H Cl}), leading to systemic alkalosis and secondary renal compensation (RAAS activation).
- The differential diagnosis between various movement disorders (PD, DLB) requires careful chronological assessment of cognitive decline versus motor symptoms.
Concept connections / cross-references
- No explicit cross-references.
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Anorexia Nervosa | Hypochloremia/Metabolic Alkalosis | Vomiting -> loss of gastric {H Cl} | Classic electrolyte triad; volume depletion activates RAAS, causing K+ wasting. |
| Cocaine Intoxication | Hypertensive Crisis | Sympathomimetic action (_1 agonism) | Requires immediate blockade of sympathetic tone using an -blocker or benzodiazepine. |
| Myasthenia Gravis | Nicotinic A Ch receptor antibodies | Autoimmune attack on the neuromuscular junction (NMJ). | Diagnosis confirmed by improvement after acetylcholinesterase inhibitors. |
| Isoniazid Toxicity | Seizures/Low GABA, High Glutamate | INH depletes pyridoxal phosphate ({B}_6), impairing glutamate decarboxylase activity. | Mandatory prophylactic {B}_6 supplementation is critical for seizure prevention. |
Key terms glossary
| Term | Definition | Context | Example |
| Anorexia Nervosa | Eating disorder characterized by self-starvation and a persistent belief of being overweight despite low BMI. | Diagnosis requires the patient to be underweight (BMI < 18.5). | A college student with a BMI of 16 who restricts calories. |
| Binge Eating Disorder | Recurrent episodes of eating large amounts of food in a short time, often feeling out of control. | Does not include compensatory behaviors like purging or excessive exercise. | Eating an entire box of cookies in one sitting without vomiting afterward. |
| -blocker (e.g., Phentolamine) | Drug class that blocks _1 adrenergic receptors. | Used to treat hypertensive crises from sympathomimetics (cocaine, MAO Is). | Administering phentolamine in a patient with cocaine-induced hypertension. |
| Pyridoxal Phosphate ({B}_6) | Active form of Vitamin B6; required cofactor for glutamate decarboxylase. | Deficiency is caused by drugs like Isoniazid (INH), leading to GABA deficiency and seizures. | Giving pyridoxine supplementation when treating latent TB with INH. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Psychiatric Syndromes | Use flowcharts/algorithms for differential diagnosis (e.g., PD vs DLB; AN vs BN vs BED). | High | Reviewing classic vignettes and neurotransmitter pathways. |
| Drug Toxicity & Crisis Mgmt | Focus on the mechanism of toxicity (e.g., {H Cl} loss, MAOI inhibition) to predict management. | Very High | Memorizing drug-specific antidotes/treatments (Prazosin for nightmares; B6 for INH). |
| Neurotransmitter Deficits | Create a table mapping the deficit (low DA, low A Ch, high DA) to the syndrome and its clinical presentation. | High | Comparing MG vs CMS, and PD vs DLB based on symptom progression. |
Question pattern recognition
- The "Must Be Underweight" Trap: For eating disorders, always check the BMI requirement for Anorexia Nervosa.
- The "Unopposed Stimulation" Trap: When treating sympathomimetic overdose (cocaine), remember that \beta-blockers are contraindicated because they leave unopposed \alpha-stimulation.
- The "Timing/Sequence" Pattern: For neurodegenerative disorders, the order of symptoms (e.g., dementia before PD in DLB) is often the key differentiator.
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing Anorexia and Bulimia. Remember that underweight is mandatory for Anorexia Nervosa; normal/overweight BMI defines Bulimia Nervosa.
🚫
Mistake 2: Mismanaging Cocaine Overdose. Do not give a \beta-blocker! The risk of unopposed \alpha_1 stimulation is life-threatening.
🚫
Mistake 3: Assuming all metabolic alkalosis from vomiting is due to volume contraction. While true, remember that the underlying mechanism involves \text{H Cl} loss and subsequent renal compensation (RAAS activation).
Common traps
⚠️
Trap 1: The Binge Eating Disorder Trap: Students often confuse BED with Bulimia Nervosa. Remember that no compensatory behavior separates them.
⚠️
Trap 2: The Anti-psychotic Timing Trap: When treating acute mania, the first step is an anti-psychotic; mood stabilizers are reserved for maintenance or poorly controlled symptoms.
⚠️
Trap 3: The Neurotransmitter Sequence Trap: For DLB, remember that cognitive decline (dementia) precedes motor symptoms (PD).
OMM / COMLEX integration
🦴
High-Yield Viscerosomatics, Autonomics & COMAT Shelf Clinical Pearls:
- Autonomic Nervous System Drug Targets: Systemic pharmacologic agents alter sympathetic and parasympathetic balance. Anticholinergic drugs (atropine, diphenhydramine) paralyze parasympathetic outflow from the vagus and pelvic splanchnics (urinary retention, ileus), while cholinergic agents (organophosphates, pyridostigmine) produce profound parasympathomimetic overactivation.
- Viscerosomatic Manifestations of Drug Toxicity: Drug-induced hepatotoxicity (acetaminophen, methotrexate) triggers acute tissue texture changes at right T5–T9 paraspinal tissues. Drug-induced interstitial nephritis (NSAIDs, penicillins) manifests at T10–L1.
- Detoxification & Lymphatics: Renal and hepatic clearance of pharmacologic metabolites is enhanced by maintaining thoracic inlet patency, ensuring unimpeded thoracic duct drainage into the left subclavian vein.